Sensei Biotherapeutics Appoints Robert Pierce, M.D., as Chief Scientific Officer

Opening of New Boston Facility Focused on Cancer Drug Development and Expansion of Expert Oncology Team GAITHERSBURG, Md. & BOSTON–(BUSINESS WIRE)–Sensei Biotherapeutics., a clinical-stage biopharmaceutical company developing precision immuno-oncology therapies, today announced the appointment of Robert Pierce, M.D., as chief scientific officer and the opening of its Boston office. Sensei’s facility in Boston will include…